This profile discusses substance-related ED visits before and during the response to COVID-19. The information provided below summarizes weekly unweighted data from a subset of 30 hospitals that fully participated in data abstraction from the first week of January through August 2020.
This is a preliminary report on the Drug Abuse Warning Network (April 2019-October 2020). The Drug Abuse Warning Network (DAWN) is a nationwide public health surveillance system administered by the Substance Abuse and Mental Health Services Administration’s (SAMHSA’s) Center for Behavioral Health Statistics and Quality (CBHSQ). DAWN captures data on...
This issue of The CBHSQ Report presents facts about substance use among young adults, including initiation, receipt of treatment, and emergency department visits for substance use \
This short report uses data from the 2010 and 2011 National Surveys on Drug Use and Health (NSDUHs), the 2010 Treatment Episode Data Set (TEDS), the 2010 National Survey of Substance Abuse Treatment Services (N-SSATS), and the 2011 Drug Abuse Warning Network (DAWN) to present facts about adolescent substance use...
This Drug Abuse Warning Network (DAWN) spotlight is about emergency department visits involving nonmedical use of central nervous system stimulants among adults age 18 to 34 increase between 2005 and 2011.
This Drug Abuse Warning Network (DAWN) short report discusses emergency department visits by children who consumed psychothapeutic drugs. It looks at the reasons for the visits (adverse reactions and accidental ingestion) for ages 0-5 and 6-11.